ask="N/A"
ask_size="N/A"
average_daily_volume="2095830"
bid="N/A"
bid_size="N/A"
book_value="0.073"
change="+0.006"
change_from_200_day_moving_average="0.039"
change_from_50_day_moving_average="0.046"
change_from_52_week_high="-0.155"
change_From_52_week_low="0.108"
change_in_percent="+2.441%"
close="0.235"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.057"
ebitda="-16.83M"
eps_estimate_current_year="-0.070"
eps_estimate_next_quarter="-0.030"
eps_estimate_next_year="-0.100"
ex_dividend_date="N/A"
float_shares="230131000"
high="0.251"
high_52_weeks="0.390"
last_trade_date="2/23/2017"
last_trade_price="0.235"
last_trade_size="123"
last_trade_time="4:02pm"
low="0.220"
low_52_weeks="0.127"
market_capitalization="55.78M"
moving_average_200_day="0.196"
moving_average_50_day="0.189"
name="Rexahn Pharmaceuticals
Inc. Co"
notes="N/A"
one_year_target_price="2.500"
open="0.225"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+20.176%"
percent_change_from_50_day_moving_average="+24.080%"
percent_change_from_52_week_high="-39.744%"
percent_change_from_52_week_low="+85.039%"
previous_close="0.229"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.142"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="237368000"
short_ratio="1.870"
stock_exchange="ASE"
symbol="RNN"
volume="2516396"
weeks_range_52="0.127 - 0.390"
